ストックスクリーナーアプリを入手
5.2886
2.85%
-0.1514
Recursion Pharmaceuticals Inc (RXRX) 最新ニュース
Recursion Pharmaceuticals to engage investors at key conferences - Traders Union
3 Things Investors Need to Know About Recursion Pharmaceuticals - The Motley Fool
Recursion (Nasdaq: RXRX) at Guggenheim, Jefferies conferences Nov. 11 and Nov. 18 - Stock Titan
Using Bollinger Bands to evaluate Recursion Pharmaceuticals Inc.Trade Exit Summary & Safe Entry Zone Identification - newser.com
How Recursion Pharmaceuticals Inc. stock reacts to bond yieldsEarnings Beat & Intraday High Probability Alerts - newser.com
AI in pharmaceuticals Market Is Booming Worldwide | Major Giants - openPR.com
Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards? - Yahoo Finance
How to interpret RSI for Recursion Pharmaceuticals Inc. stockTreasury Yields & Proven Capital Preservation Tips - newser.com
Will earnings trigger a reversal in Recursion Pharmaceuticals Inc.July 2025 Fed Impact & High Yield Stock Recommendations - newser.com
Is Recursion Pharmaceuticals Inc. stock poised for growthWeekly Trade Recap & Reliable Breakout Stock Forecasts - newser.com
How Recursion Pharmaceuticals Inc. stock valuations compare to rivals2025 AllTime Highs & High Conviction Trade Alerts - newser.com
Will Recursion Pharmaceuticals Inc. stock maintain growth storyQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com
When is the best time to exit Recursion Pharmaceuticals Inc.Quarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com
Biotech Stocks To Add to Your WatchlistOctober 30th - MarketBeat
Is it time to cut losses on Recursion Pharmaceuticals Inc.July 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
Top Biotech Stocks To Follow TodayNovember 1st - MarketBeat
Can Recursion Pharmaceuticals Inc. stock hit record highs againStock Surge & Real-Time Market Sentiment Alerts - newser.com
Recursion Pharmaceuticals (RXRX) Stock: CEO Sells $5.8 Million in Shares Following Exscientia Merger - CoinCentral
Top Biotech Stocks To Keep An Eye OnOctober 28th - MarketBeat
Best Biotech Stocks To Follow TodayOctober 31st - MarketBeat
Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Merger and Partnerships - Quiver Quantitative
Signal strength of Recursion Pharmaceuticals Inc. stock in tech scannersGlobal Markets & Free High Return Stock Watch Alerts - newser.com
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock? - The Globe and Mail
Has Recursion Pharmaceuticals Inc. formed a bullish divergenceVolume Spike & Real-Time Price Movement Reports - newser.com
BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fierce Biotech
Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline - sharewise.com
Recursion Pharmaceuticals Incannounces Roche's exercise of option for Microglia MapSEC filing - MarketScreener
Roche Exercises Option with Recursion Pharmaceuticals - TipRanks
Recursion Pharmaceuticals Announces Roche's Option Exercise - TradingView
Published on: 2025-10-29 07:02:21 - newser.com
Recursion Pharmaceuticals (RXRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Is Hindustan Media Ventures Limited Stock Poised for a Breakout in YEARVolume Weighted Average Price & Master Stock Selection - earlytimes.in
Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors - sharewise.com
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Recursion Pharmaceuticals, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
Recursion Pharmaceuticals (RXRX): Exploring Valuation as AI Expansion, Key Merger, and Clinical Progress Boost Interest - simplywall.st
1.53%
大文字化:
|
ボリューム (24 時間):